(Q46879294)

26 December 2017

title

Vascular endothelial growth factor-d modulates caliber and function of initial lymphatics in the dermis (English)

1 reference

26 December 2017

Cameron J Nowell

7

0 references

Marc G Achen

Marc G Achen

12

0 references

Steven A Stacker

Steven A Stacker

11

0 references

Sally Roufail

8

Sally Roufail

1 reference

26 December 2017

Tara Karnezis

5

Tara Karnezis

1 reference

26 December 2017

Ramin Ghasemi Shayan

4

Ramin Shayan

1 reference

26 December 2017

Sophie Paquet-Fifield

1

Sophie Paquet-Fifield

1 reference

26 December 2017

You-Fang Zhang

10

You-Fang Zhang

1 reference

26 December 2017

Teruhiko Sato

3

Teruhiko Sato

1 reference

26 December 2017

author name string

Sidney M Levy

2

1 reference

26 December 2017

Natalia Davydova

6

1 reference

26 December 2017

Gerry Zhi-Ming Ma

9

1 reference

26 December 2017

language of work or name

English

0 references

publication date

25 February 2013

1 reference

26 December 2017

Journal of Investigative Dermatology

published in

1 reference

26 December 2017

volume

133

1 reference

26 December 2017

issue

8

1 reference

26 December 2017

page(s)

2074-2084

1 reference

26 December 2017

https://scigraph.springernature.com/pub.10.1038/jid.2013.83

exact match

0 references

cites work

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Targeting lymphangiogenesis to prevent tumour metastasis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Focus on lymphangiogenesis in tumor metastasis.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Monoclonal antibodies to vascular endothelial growth factor-D block its interactions with both VEGF receptor-2 and VEGF receptor-3.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Molecular control of lymphatic metastasis.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Localization of vascular endothelial growth factor-D in malignant melanoma suggests a role in tumour angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

The lymphatic vasculature in disease

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

The specificity of receptor binding by vascular endothelial growth factor-d is different in mouse and man

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Vascular endothelial growth factor D is dispensable for development of the lymphatic system

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Multiple forms of mouse vascular endothelial growth factor-D are generated by RNA splicing and proteolysis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Molecular control of lymphangiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Angiogenic Responses of Vascular Endothelial Growth Factors in Periadventitial Tissue

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Adenovirus encoding vascular endothelial growth factor-D induces tissue-specific vascular patterns in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

The lymphatic system in health and disease

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Sox18 induces development of the lymphatic vasculature in mice

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Fibroblasts, myofibroblasts, and wound contraction

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Deletion of vascular endothelial growth factor C (VEGF-C) and VEGF-D is not equivalent to VEGF receptor 3 deletion in mouse embryos

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Proteolytic processing of vascular endothelial growth factor-D is essential for its capacity to promote the growth and spread of cancer

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

An important role of lymphatic vessel activation in limiting acute inflammation

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Activation of the VEGFR-3 pathway by VEGF-C attenuates UVB-induced edema formation and skin inflammation by promoting lymphangiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Functional interaction of VEGF-C and VEGF-D with neuropilin receptors

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Lymphangiogenic growth factor responsiveness is modulated by postnatal lymphatic vessel maturation

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

VEGF-D deficiency in mice does not affect embryonic or postnatal lymphangiogenesis but reduces lymphatic metastasis.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Distinct roles of vascular endothelial growth factor-D in lymphangiogenesis and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

In vivo imaging of lymphatic vessels in development, wound healing, inflammation, and tumor metastasis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Proprotein convertases promote processing of VEGF-D, a critical step for binding the angiogenic receptor VEGFR-2

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Role of VEGF-D and VEGFR-3 in developmental lymphangiogenesis, a chemicogenetic study in Xenopus tadpoles.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

The lymphatic vasculature: recent progress and paradigms

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Mice null for sox18 are viable and display a mild coat defect

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Vascular endothelial growth factor-D expression in human atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Lymphatic vessels in cancer metastasis: bridging the gaps

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

A system for quantifying the patterning of the lymphatic vasculature

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Relationship between lymphangiogenesis and exudates during the wound-healing process of mouse skin full-thickness wound

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

VEGF-D promotes the metastatic spread of tumor cells via the lymphatics

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Lymphangiogenic growth factors as markers of tumor metastasis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Inflammatory manifestations of experimental lymphatic insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Lymphangiogenesis: Molecular mechanisms and future promise

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

The lymphangiogenic vascular endothelial growth factors VEGF-C and -D are ligands for the integrin alpha9beta1

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Viral Vascular Endothelial Growth Factors Vary Extensively in Amino Acid Sequence, Receptor-binding Specificities, and the Ability to Induce Vascular Permeability yet Are Uniformly Active Mitogens

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.83

7 January 2021

Identifiers

DOI

10.1038/JID.2013.83

1 reference

26 December 2017

PubMed ID

23439394

1 reference

26 December 2017